These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 30707297

  • 1. Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant.
    Chen X, Li B, Yu J, Zhang Y, Mo Z, Gu T, Kong W, Zhang Y, Wu Y.
    Med Microbiol Immunol; 2019 Apr; 208(2):215-226. PubMed ID: 30707297
    [Abstract] [Full Text] [Related]

  • 2. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J, Sun T, Wang D, Dong Y, Xu M, Hou H, Kong FT, Liang C, Gu T, Chen P, Sun S, Lv X, Jiang C, Kong W, Wu Y.
    Immunol Invest; 2015 Apr; 44(5):482-96. PubMed ID: 26107747
    [Abstract] [Full Text] [Related]

  • 3. A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains.
    Yu J, Chen X, Li B, Gu T, Meng X, Kong W, Wu Y.
    Immunol Res; 2018 Aug; 66(4):528-536. PubMed ID: 30128745
    [Abstract] [Full Text] [Related]

  • 4. Recombinant BCG expressing a PspA-PdT fusion protein protects mice against pneumococcal lethal challenge in a prime-boost strategy.
    Goulart C, Rodriguez D, Kanno AI, Lu YJ, Malley R, Leite LC.
    Vaccine; 2017 Mar 23; 35(13):1683-1691. PubMed ID: 28242071
    [Abstract] [Full Text] [Related]

  • 5. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
    Li B, Chen X, Yu J, Zhang Y, Mo Z, Gu T, Kong W, Wu Y.
    Microb Pathog; 2018 Oct 23; 123():115-119. PubMed ID: 29959043
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae.
    Vadesilho CF, Ferreira DM, Moreno AT, Chavez-Olortegui C, Machado de Avila RA, Oliveira ML, Ho PL, Miyaji EN.
    Microb Pathog; 2012 Oct 23; 53(5-6):243-9. PubMed ID: 22981893
    [Abstract] [Full Text] [Related]

  • 8. Comparison of Immunogenicity and Protection of Two Pneumococcal Protein Vaccines Based on PsaA and PspA.
    Yu J, Li B, Chen X, Lu J, Wang D, Gu T, Kong W, Wu Y.
    Infect Immun; 2018 Jun 23; 86(6):. PubMed ID: 29610257
    [Abstract] [Full Text] [Related]

  • 9. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO, Ding X, Briles DE, Jacobs MR, Greenspan NS.
    Infect Immun; 2005 Mar 23; 73(3):1304-12. PubMed ID: 15731027
    [Abstract] [Full Text] [Related]

  • 10. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
    Bitsaktsis C, Iglesias BV, Li Y, Colino J, Snapper CM, Hollingshead SK, Pham G, Gosselin DR, Gosselin EJ.
    Infect Immun; 2012 Mar 23; 80(3):1166-80. PubMed ID: 22158740
    [Abstract] [Full Text] [Related]

  • 11. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT, Kim SY, Kim MS, Lee SE, Rhee JH.
    Vaccine; 2011 Aug 05; 29(34):5731-9. PubMed ID: 21696869
    [Abstract] [Full Text] [Related]

  • 12. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.
    Arévalo MT, Xu Q, Paton JC, Hollingshead SK, Pichichero ME, Briles DE, Girgis N, Zeng M.
    FEMS Immunol Med Microbiol; 2009 Apr 05; 55(3):346-51. PubMed ID: 19291171
    [Abstract] [Full Text] [Related]

  • 13. Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
    Chen A, Mann B, Gao G, Heath R, King J, Maissoneuve J, Alderson M, Tate A, Hollingshead SK, Tweten RK, Briles DE, Tuomanen EI, Paton JC.
    Clin Vaccine Immunol; 2015 Oct 05; 22(10):1079-89. PubMed ID: 26245351
    [Abstract] [Full Text] [Related]

  • 14. PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae.
    Miyaji EN, Dias WO, Gamberini M, Gebara VC, Schenkman RP, Wild J, Riedl P, Reimann J, Schirmbeck R, Leite LC.
    Vaccine; 2001 Dec 12; 20(5-6):805-12. PubMed ID: 11738744
    [Abstract] [Full Text] [Related]

  • 15. Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide.
    Lu YJ, Forte S, Thompson CM, Anderson PW, Malley R.
    Infect Immun; 2009 May 12; 77(5):2076-83. PubMed ID: 19255193
    [Abstract] [Full Text] [Related]

  • 16. PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae.
    Xin W, Li Y, Mo H, Roland KL, Curtiss R.
    Infect Immun; 2009 Oct 12; 77(10):4518-28. PubMed ID: 19687204
    [Abstract] [Full Text] [Related]

  • 17. [Immunoprotective effect of combined pneumococcal endopeptidase O and pneumococcal surface adhesin A vaccines against Streptococcus pneumoniae infection].
    Zhang J, Cui YL, Jiang YM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 May 12; 19(5):583-589. PubMed ID: 28506354
    [Abstract] [Full Text] [Related]

  • 18. Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.
    Tostes RO, Rodrigues TC, da Silva JB, Schanoski AS, Oliveira ML, Miyaji EN.
    PLoS One; 2017 May 12; 12(1):e0170157. PubMed ID: 28103277
    [Abstract] [Full Text] [Related]

  • 19. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
    Lin H, Peng Y, Lin Z, Zhang S, Guo Y.
    Microb Pathog; 2015 May 12; 83-84():35-40. PubMed ID: 25959527
    [Abstract] [Full Text] [Related]

  • 20. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Xu JH, Dai WJ, Chen B, Fan XY.
    Scand J Immunol; 2015 Mar 12; 81(3):177-85. PubMed ID: 25565478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.